Increased risk of hospitalisation and death with the delta variant in the USA.
作者信息
Bast Elizabeth, Tang Fei, Dahn Jason, Palacio Ana
机构信息
Department of Ambulatory Medicine, Bruce W Carter VA Medical Center, Miami, FL 33125, USA.
Geriatric Research Education and Clinical Center, Bruce W Carter VA Medical Center, Miami, FL 33125, USA.
出版信息
Lancet Infect Dis. 2021 Dec;21(12):1629-1630. doi: 10.1016/S1473-3099(21)00685-X.
Abstract
摘要
相似文献
1
Increased risk of hospitalisation and death with the delta variant in the USA.在美国，感染德尔塔变种导致住院和死亡的风险增加。
Lancet Infect Dis. 2021 Dec;21(12):1629-1630. doi: 10.1016/S1473-3099(21)00685-X.
2
COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study.根据美国 SARS-CoV-2 德尔塔（B.1.617.2）变异株流行期间脆弱性状况，评估 COVID-19 mRNA 疫苗对退伍军人住院和死亡的有效性：一项回顾性队列研究。
Lancet Healthy Longev. 2022 Sep;3(9):e589-e598. doi: 10.1016/S2666-7568(22)00166-0. Epub 2022 Aug 1.
3
A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study.对 COVID-19 病死率及其季节性趋势的时间序列回顾，以及对美国 Delta 和奥密克戎浪潮期间全因死亡率和住院治疗的调查：一项回顾性队列研究。
Front Public Health. 2023 Sep 15;11:1143650. doi: 10.3389/fpubh.2023.1143650. eCollection 2023.
4
Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.成人因实验室确诊的 COVID-19 住院的严重程度在 SARS-CoV-2 B.1.617.2（Delta）流行之前和期间-COVID-NET，14 个州，2021 年 1 月至 8 月。
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1513-1519. doi: 10.15585/mmwr.mm7043e1.
5
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.与德尔塔变异株相比，报告的 COVID-19 病例中感染 SARS-CoV-2 奥密克戎 BA.1 变异株的住院风险降低，挪威，2021 年 12 月至 2022 年 1 月。
Euro Surveill. 2022 Jan;27(4). doi: 10.2807/1560-7917.ES.2022.27.4.2200077.
6
Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization - United States, March 2020-September 2021.COVID-19 住院分娩的孕妇与非 COVID-19 住院分娩的孕妇发生死胎的风险-美国，2020 年 3 月至 2021 年 9 月。
MMWR Morb Mortal Wkly Rep. 2021 Nov 26;70(47):1640-1645. doi: 10.15585/mmwr.mm7047e1.
7
COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.COVID-19 相关住院病例在 SARS-CoV-2 德尔塔和奥密克戎变异株流行期间的种族/民族差异和疫苗接种状况分析——COVID-NET，14 个州，2021 年 7 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):466-473. doi: 10.15585/mmwr.mm7112e2.
8
An Analysis of COVID-19 Mortality During the Dominancy of Alpha, Delta, and Omicron in the USA.美国 Alpha、Delta 和奥密克戎变异株流行期间 COVID-19 死亡率分析。
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231170164. doi: 10.1177/21501319231170164.
9
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.疾病严重程度和医疗保健利用趋势在奥密克戎变异株早期与之前 SARS-CoV-2 高传播期相比-美国，2020 年 12 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4.
10
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.COVID-19 发病率和死亡率在有和没有加强针的未接种和完全接种成年人中，在德尔塔和奥密克戎变体出现期间-25 个美国司法管辖区，2021 年 4 月 4 日至 12 月 25 日。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):132-138. doi: 10.15585/mmwr.mm7104e2.
引用本文的文献
1
SARS-CoV-2 epidemiology, kinetics, and evolution: A narrative review.严重急性呼吸综合征冠状病毒2型的流行病学、动力学及进化：一篇综述
Virulence. 2025 Dec;16(1):2480633. doi: 10.1080/21505594.2025.2480633. Epub 2025 Apr 8.
2
Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis.运用扰动分析评估比利时儿童在新冠疫情中的作用。
Nat Commun. 2025 Mar 5;16(1):2230. doi: 10.1038/s41467-025-57087-z.
3
Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands.2023年秋季荷兰新冠病毒mRNA XBB.1.5疫苗接种的成本效益分析
Adv Ther. 2025 Mar;42(3):1550-1569. doi: 10.1007/s12325-025-03112-y. Epub 2025 Feb 10.
4
Efficacy and safety of early administration of remdesivir in hemodialysis patients with COVID-19: A case report and literature review.COVID-19 血液透析患者早期使用瑞德西韦的疗效和安全性：病例报告及文献复习。
Medicine (Baltimore). 2024 Nov 29;103(48):e40650. doi: 10.1097/MD.0000000000040650.
5
Tracking temporal variations of fatality and symptomology correlated with COVID-19 dominant variants and vaccine effectiveness in the United States.追踪与 COVID-19 主要变异株和疫苗有效性相关的病死率和症状学的时间变化在美国。
Front Public Health. 2024 Sep 18;12:1419886. doi: 10.3389/fpubh.2024.1419886. eCollection 2024.
6
Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution.早期、强烈的口腔液中针对严重急性呼吸综合征冠状病毒2刺突蛋白的黏膜分泌型免疫球蛋白A而非免疫球蛋白G反应与病毒更快清除及2019冠状病毒病症状缓解相关。
J Infect Dis. 2025 Feb 4;231(1):121-130. doi: 10.1093/infdis/jiae447.
7
Handgrip strength as a prognostic factor for COVID-19 mortality among older adult patients admitted to the intensive care unit (ICU): a comparison Alpha (B.1.1.7) and Delta (B.1.617.2) variants.握力作为入住重症监护病房（ICU）老年患者 COVID-19 死亡率的预后因素：Alpha（B.1.1.7）和 Delta（B.1.617.2）变异株的比较。
Sci Rep. 2024 Aug 27;14(1):19927. doi: 10.1038/s41598-024-71034-w.
8
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies.CAR-37 T 细胞治疗复发或难治性 CD37+淋巴肿瘤患者的 1 期临床研究。
Blood. 2024 Sep 12;144(11):1153-1167. doi: 10.1182/blood.2024024104.
9
Human judgement forecasting of COVID-19 in the UK.英国对新冠疫情的人类判断预测。
Wellcome Open Res. 2024 Mar 21;8:416. doi: 10.12688/wellcomeopenres.19380.2. eCollection 2023.
10
Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population.接种 Ad5-nCoV（康希诺）后对 SARS-CoV-2 的 Delta 变异株的中和抗体反应在墨西哥人群中。
PLoS One. 2024 Apr 4;19(4):e0299520. doi: 10.1371/journal.pone.0299520. eCollection 2024.
本文引用的文献
1
Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance - Nine States, June-August 2021.2021 年 6 月至 8 月，在 SARS-CoV-2 B.1.617.2（德尔塔）变异株流行期间，九州成年人因 COVID-19 前往急诊科或紧急护理诊所和住院的 COVID-19 疫苗有效性的临时估计
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1291-1293. doi: 10.15585/mmwr.mm7037e2.
2
Hospitalisation associated with SARS-CoV-2 delta variant in Denmark.丹麦与新冠病毒德尔塔变异株相关的住院情况。
Lancet Infect Dis. 2021 Oct;21(10):1351. doi: 10.1016/S1473-3099(21)00580-6. Epub 2021 Sep 3.
3
Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population.高危国家人群接种疫苗后出现严重急性呼吸综合征冠状病毒2型突破性感染患者的结局。
EClinicalMedicine. 2021 Aug 28;40:101117. doi: 10.1016/j.eclinm.2021.101117. eCollection 2021 Oct.
4
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.与关注的阿尔法（B.1.1.7）变体相比，感染新冠病毒德尔塔（B.1.617.2）变体的住院和急诊就诊风险：一项队列研究。
Lancet Infect Dis. 2022 Jan;22(1):35-42. doi: 10.1016/S1473-3099(21)00475-8. Epub 2021 Aug 27.
Zotero 插件